Ark Therapeutics Group (AKT)

 0.43p
   
  • Change Today:
      0.000p
  • 52 Week High: 3.58
  • 52 Week Low: 0.36
  • Currency: UK Pounds
  • Shares Issued: 209.28m
  • Volume: 0
  • Market Cap: £0.90m
  • RiskGrade: 677
  • Beta: 0.31

AKT Overview

Ark Therapeutics Group is in the pharmaceuticals & biotechnology sector and is currently trading at 0.43p per share. In the last year Ark Therapeutics Group's share price has ranged from 0.36p to 3.58p.

1 Day Chart (17-06-2013)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -713.4% -155.3%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 0.5 0.2
Pr/Book 0.3  
Latest F'cast
Revenue -74.5% 120.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

AKT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-08 0.93 (17.60) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-09 1.39 (20.21) (9.00)p n/a n/a n/a n/a 0.0%
31-Dec-10 0.76 (16.94) (6.77)p n/a n/a n/a n/a 0.0%
31-Dec-11 7.13 (4.44) (1.80)p n/a n/a n/a n/a 0.0%
31-Dec-12 1.82 (12.96) (6.20)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AKT Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-13 4.00 (6.21) (2.60)p n/a n/a n/a n/a 0.0%
31-Dec-14 4.80 (6.38) (2.80)p n/a n/a n/a n/a 0.0%

Copyright © 2013 FactSet Research Systems Inc. All rights reserved.

AKT Company Announcements

Second Price Monitoring Extn 14-Jun-2013 16:40 RNS
Price Monitoring Extension 14-Jun-2013 16:35 RNS
Blocklisting Six Monthly Return 04-Jun-2013 14:48 RNS

Latest AKT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AKT Market Data

Currency UK Pounds
Share Price 0.43p
Change Today 0.000p
% Change 0.00 %
52 Week High 3.58
52 Week Low 0.36
Volume 0
Shares Issued 209.28m
Market Cap £0.90m
Beta 0.31
RiskGrade 677

AKT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.53% above the market average51.53% above the market average51.53% above the market average51.53% above the market average51.53% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average
Price Trend
97.51% below the market average97.51% below the market average97.51% below the market average97.51% below the market average97.51% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
25.56% above the market average25.56% above the market average25.56% above the market average25.56% above the market average25.56% above the market average
28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average28.21% above the sector average

AKT Dividends

No dividends found

Trades for --2013

Time Volume / Share Price
0 @ 0.000p

AKT Key Personnel

CEO Martyn Williams
CFO Russell Banks

Top of Page